The effects of pentoxifylline on bacterial translocation after intestinal obstruction

Shock

Volumn 18, Issue 2, 2002, Pages 148-151

  Kocdor, Mehmet Ali ^a   Kocdor, Hilal ^a   Gulay, Zeynep ^a   Gokce, Ozcan ^a  

^a DOKUZ EYLUL UNIVERSITY   (Turkey)

Author keywords

Bacterial translocation; Intestinal obstruction; Pentoxifylline

Indexed keywords

PENTOXIFYLLINE;

ANALYSIS OF VARIANCE; ANIMAL; ARTICLE; BACTERIAL COUNT; BACTERIAL INFECTION; BACTERIAL TRANSLOCATION; CHI SQUARE DISTRIBUTION; COMPARATIVE STUDY; DISEASE MODEL; DOSE RESPONSE; DRUG ADMINISTRATION; DRUG EFFECT; FEMALE; INTESTINE MUCOSA; INTESTINE OBSTRUCTION; MICROBIOLOGY; PHYSIOLOGY; PROBABILITY; RANDOMIZATION; RAT; REFERENCE VALUE; SEPTIC SHOCK; SUBCUTANEOUS DRUG ADMINISTRATION; WISTAR RAT;

ANALYSIS OF VARIANCE; ANIMALS; BACTERIAL INFECTIONS; BACTERIAL TRANSLOCATION; CHI-SQUARE DISTRIBUTION; COLONY COUNT, MICROBIAL; DISEASE MODELS, ANIMAL; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG ADMINISTRATION SCHEDULE; FEMALE; INJECTIONS, SUBCUTANEOUS; INTESTINAL MUCOSA; INTESTINAL OBSTRUCTION; PENTOXIFYLLINE; PROBABILITY; RANDOM ALLOCATION; RATS; RATS, WISTAR; REFERENCE VALUES; SHOCK, SEPTIC;

EID: 0036691782     PISSN: 10732322     EISSN: None     Source Type: Journal    
DOI: 10.1097/00024382-200208000-00010     Document Type: Article

References (45)

1. Deitch EA: Multiple organ failure: pathophysiology and potential future therapy. Ann Surg 216(2): 117-134, 1992.
2. Nieuwenhuijzen GA, Deitch EA, Goris RJA: Infection, the gut and the development of the multiple organ dysfunction syndrome. Eur J Surg 162:259-273, 1996.
3. Swank GM, Deitch EA: Role of the gut in multiple organ failure: bacterial translocation and permeability changes. World J Surg 20(4):411-417, 1996.
4. Deitch EA, Sittig K, Li M, Berg RD, Specian RD: Obstructive jaundice promotes bacterial translocation from the gut. Am J Surg 159:79-84, 1990.
5. Deitch EA, Bridges W, Wen Ma J, Li Ma, Berg RD, Specian RD: Obstructed intestine as a reservoir for systemic infection. Am J Surg 159:394-404, 1990.
6. Eaves-Pyles T, Alexander JW: Rapid and prolonged impairment of gut barrier function after thermal injury in mice. Shock 9(2):95-100, 1998.
7. Eleftheriadis E, Kotzampassi K, Papanotas K, Heliadis N, Sarris K: Gut ischemia, oxidative stress, and bacterial translocation in elevated abdominal pressure in rats. World J Surg 20(1):11-16, 1996.
8. Kale IT, Kuzu MA, Berkem H, Berkem R, Acar N: The presence of hemorrhagic shock increases the rate of bacterial translocation in blunt abdominal trauma. J Trauma 44(1):171-174, 1998.
9. Sagar PM, MacFie J, Sedman P, May J, Mancey-Jones B, Johnstone D: Intestinal obstruction promotes gut translocation of bacteria. Dis Colon Rectum 38:640-644, 1995.
10. Tani T, Fujino M, Hanasawa K, Shimizu T, Endo Y, Kodama M: Bacterial translocation and tumor necrosis factor-α gene expression in experimental hemorrhagic shock. Crit Care Med 28(11):3705-3709, 2000.
11. Chalkiadakis GE, Kostakis A, Karayannacos PE, Chalkiadakis ME: Pentoxifylline in the treatment of experimental peritonitis in rats. Arch Surg 120(10): 1141-1145, 1985.
12. Price CL, JW Horton: The effects of pentoxifylline on bacterial peritonitis. Curr Surg 46:308-311, 1989.
13. Wu CC, Liao MH, Chen SJ, Yen MH: Pentoxifylline improves circulatory failure and survival in murine models of endotoxaemia. Eur J Pharmacol 28;373(1):41-49, 1999.
14. Wattanasirichaigoon S, Menconi MJ, Delude RL, Fink MP: Lysofylline ameliorates intestinal mucosal barrier dysfuction caused by ischemia and ischemia/ reperfusion. Shock 11(4):269-275, 1999.
15. Lauterbach R, Zembala M: Pentoxifylline reduces plasma tumour necrosis factor-a concentrations in premature infants with sepsis. Eur J Pediatr 155(5): 404-409, 1999.
16. Ehrhart I, McLoud L, Creamer KM, Ocasio H: Pentoxifylline markedly reduces pulmonary neutrophil sequestration. Chest 116(Suppl 1):34S, 1996.
17. Cicalese L, Yacoub W, Rogers J, Fung JJ, Rao AS, Starzl TE: Translocation of bacteria from gastrointestinal tract: protection afforded by lisofylline. Transplant Proc 31:575-576, 1999.
18. Yada-Langui MM, Coimbra R, Lancellotti C, Mimica I, Garcia C, Correia N Jr, Rochae Silva M: Hypertonic saline and pentoxifylline prevent lung injury and bacterial translocation after hemorrhagic shock. Shock 14(6):594-598, 2000.
19. Akyildiz M, Ersin S, Oymaci E, Dayangac M, Kapkac M, Alkanat M: Effects of somatostatin analogues and vitamin C on bacterial translocation in an experimental intestinal obstruction model of rats. J Invest Surg 13(3):169-173, 2000.
20. Sedman PC, MacFie J, Sagar P, Mitchell CJ, May J, Mancey-Jones B, Johnstone D: Prevalance of gut translocation in humans. Gastroenterology 107: 643-649, 1994.
21. Steffen EK, Berg RD, Deitch EA: Comparison of the translocation rates of indigenous bacteria from the gastrointestinal tract to the mesenteric lymph node. J Infect Dis 157:1032-1037, 1988.
22. Ward A, Clissold SP: Pentoxifylline: a rewiev of its pharmacodynamic and pharmacokinetic properties and its therapeutic efficacy. Drugs 34:50-97, 1987.
23. Enochsson L, Nylander G, Öhman U: Effects of intraluminal pressure on regional blood flow in the obstructed and unobstructed small intestines in the rat. Am J Surg 144(5):558-561, 1982.
24. Xu DZ, Lu Q, Kubicka R, Deitch EA: The effect of hypoxia/reoxygenation on the cellular function of intestinal epithelial cells. J Trauma 46(2):280-285, 1999.
25. Grotz MRW, Deitch EA, Ding J, Xu D, Huang Q, Regel G: Intestinal cytokine response after gut ischemia: role of gut barrier failure. Ann Surg 229(4):478-486, 1999.
26. Sun Z, Wang X, Deng X, Borjesson A, Wallen R, Hallberg E, Andersson R: Phagocytic and intestinal endothelial and epithelial barrier function during the early stage of small intestinal ischemia and reperfusion injury. Shock 13(3): 209-216, 2000.
27. Granger DN: Role of xanthine oxidase and granulocytes in ischemia-reperfusion injury. Am J Physiol Heart Circ Physiol 255:H1269-H1275, 1988.
28. Kishi M, Tanaka H, Seiyama A, Takoaka A, Matsuoka T, Yoshioka T, Sugimoto H: Pentoxifylline attenuates reperfusion injury in skeletal muscle after partial ischemia. Am J Physiol Heart Circ Physiol 274 (43):H1435-H1442, 1998.
29. Fabia R, Travis DL, Levy MF, Husberg BS, Goldstein RM, Klintmalm GB: Effect of pentoxifylline on hepatic ischemia and reperfusion injury. Surgery 121:520-525, 1997.
30. Mavrelis PG, Doumanian H: Pentoxifylline for mesenteric ischemia Am J Gastroenterol 82:175, 1987.
31. Myers SI, Horton JW, Hernandez R, Walker PB, Waughan WG: Pentoxifylline protects splenachnic prostacycline synthesis during mesenteric ischemia-reperfusion Prostaglandins 47:137-150, 1994.
32. Akgur F, Zibari GB, McDonald JC, Granger DN, Brown MF: Effects of Dextran and pentoxifylline on hemorrhagic shock-induced P-selectin expression. J Surg Res 87:232-238, 1999.
33. Crouch SPM, Fletcher J: Effect of ingested pentoxifylline on neutrophil superoxide anion production. Infect Immun 60(11):4504-4509, 1992.
34. Hammerman C, Goldschmidt D, Caplan MS, Kaplan M, Schimmel MS, Eidelman AI, Branski D, Hochman A: Amelioration of ischemia-reperfusion injury in rat intestine by pentoxifylline-mediated inhibition of xanthine oxidase. J Pediatr Gastroenterol Nutr 29(1):69-74, 1999.
35. Samlaska CP, Winfield EA: Pentoxifylline. J Am Acad Dermatol 30:603-621, 1994.
36. Grotz MR, Ding J, Guo W, Huang Q, Deitch EA: Comparison of plasma cytokine levels in rats subjected to superior mesenteric artery occlusion or hemorrhagic shock. Shock 3(5):362-368, 1995.
37. Sorkine P, Szold O, Halpern P, Gutman M, Greemland M, Rudick V, Goldman G: Gut decontamination reduces bowel ischemia-induced lung injury in rats. Chest 112(2):491-495, 1997.
38. Goldman G, Soffer D, Heller L, Aderka D, Lahat A, Klausner JM: Tumor necrosis factor mediates bacterial translocation after haemorrhagic shock and endotoxaemia. Eur J Surg 167:299-304, 2001.
39. Nieuwenhuijzen GA, Haskel Y, Lu Q, Berg RD, van Rooijen N, Goris RJ, Deitch EA: Macrophage elimination increases bacterial translocation and gut-origin septicemia but attenuates symptoms and mortality rate in a model of systemic inflammation. Ann Surg 218(6):791-799, 1993.
40. Reynolds JV, Murchan P, Redmond HP, Watson RW, Leonard N, Hill A, Clarke P, Marks P, Keane FB, Tanner WA: Failure of macrophage activation in experimental obstructive jaundice: association with bacterial translocation. Br J Surg 82(4):534-538, 1995.
41. Wang X, Andersson R, Soltesz V, Leveau P, Ihse I: Gut origin sepsis, macrophage function, and oxygen extraction associated with acute pancreatitis in the rat. World J Surg 20(3):299-307, 1996.
42. Josaki K, Contrino J, Kristie J, Kraus P, Kreutzer DL: Pentoxifyllin-induced modulation of human leukocyte function in vitro. Am J Pathol 136:623-630, 1990.
43. Krause PJ, Kristie J, Wang W-P, Eisenfeld L, Herson VC, Maderano EG, Jozaki K, Kreutzer DL: Pentoxifylline enhancement of defective neutrophil function and host defence in neonatal mice. Am J Pathol 129:217-222, 1987.
44. Wenisch C, Zedwitz-Liebenstein K, Parschalk B, Graninger W: Effect of pentoxifylline in vitro on neutrophil reactive oxigen production and phagocytic ability assessed by flow cytometry. Clin Drug Invest 13(2):99-104, 1997.
45. Heller S, Weber K, Heller A, Urbaschek R, Koch T: Pentoxifylline improves bacterial clearance during hemorrhage and endotoxemia. Crit Care Med 27(4): 756-763, 1999.